Item 21 of 22 (back to results) previous next gadoterate meglumine An organoammonium salt obtained by reaction of gadoteric acid with one equivalent of 1-deoxy-1-(methylamino)-D-glucitol (meglumine). It is used in magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues of patients ages 2 years and older, to detect and visualise areas with disruption of the blood brain barrier and/or abnormal vascularity of the central nervous system.

Current search: 08. Chemical Category: transition element molecular entity [CHEBI:33497] > f-block molecular entity [CHEBI:33677] > lanthanoid molecular entity [CHEBI:33775] × Select any link to see items in a related category. more general categories    information about this item 05. Industrial Uses  05. Industrial Uses  pharmaceutical [CHEBI:52217] (1978)   diagnostic agent [CHEBI:33295] (53)   diagnostic imaging agent [CHEBI:37334] (32)   MRI contrast agent [CHEBI:37335] (9)   gadoterate meglumine [CHEBI:73727] (1) 08. Chemical Category  08. Chemical Category  transition element molecular entity [CHEBI:33497] (536)   f-block molecular entity [CHEBI:33677] (36)   lanthanoid molecular entity [CHEBI:33775] (22)   lanthanoid coordination entity [CHEBI:35728] (17)   gadolinium coordination entity [CHEBI:35730] (13)   gadoterate meglumine [CHEBI:73727] (1)  gadolinium molecular entity [CHEBI:35729] (15)   gadolinium coordination entity [CHEBI:35730] (13)   gadoterate meglumine [CHEBI:73727] (1)  main group molecular entity [CHEBI:33579] (25650)   p-block molecular entity [CHEBI:33675] (25343)   pnictogen molecular entity [CHEBI:33302] (10027)   nitrogen molecular entity [CHEBI:51143] (7930)   ammonium compound [CHEBI:35276] (129)   organoammonium salt [CHEBI:46850] (104)   gadoterate meglumine [CHEBI:73727] (1) ChEBI Compound Accession Identifier:   [CHEBI:73727] ChEBI Compound Description:   An organoammonium salt obtained by reaction of gadoteric acid with one equivalent of 1-deoxy-1-(methylamino)-D-glucitol (meglumine). It is used in magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues of patients ages 2 years and older, to detect and visualise areas with disruption of the blood brain barrier and/or abnormal vascularity of the central nervous system. ChEBI Compound Identification Number:   73727 ChEBI InChI Value:   "InChI=1S/C16H28N4O8.C7H17NO5.Gd/c21-13(22)9-17-1-2-18(10-14(23)24)5-6-20(12-16(27)28)8-7-19(4-3-17)11-15(25)26;1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-12H2,(H,21,22)(H,23,24)(H,25,26)(H,27,28);4-13H,2-3H2,1H3;/q;;+3/p-3/t;4-,5+,6+,7+;/m.0./s1" ChEBI InChIKey Value:   RYHQMKVRYNEBNJ-BMWGJIJESA-K ChEBI Compound Name:   gadoterate meglumine ChEBI SMILES Value:   CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)C[N+]12CC[N+]3(CC[N+]4(CC[N+](CC1)(CC([O-])=O)[Gd-]234)CC([O-])=O)CC([O-])=O ChEBI Substance ID:   163425822 ChEBI URL:   ChEBI:73727 ChemSpider ID:   5293254 Ontomatica Chemical Accession Key (OnChAKey):   RYHQMKVRYNEBNJ_BMWGJIJESA_K_000_000000 PubChem Compound ID:   71464586